| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Pulmonary disease, chronic obstructive, severe early-onset | 0.456 | 0.885 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2017 | 2020 | |||||||||
|
microRNA 184 | 0.542 | 0.769 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2013 | |||||||||
|
adenylate kinase 6 | 0.678 | 0.538 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
baculoviral IAP repeat containing 8 | 0.861 | 0.192 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
cancer/testis antigen 1B | 0.507 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
cancer/testis antigen 1A | 0.508 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
immunoglobulin heavy constant gamma 1 (G1m marker) | 0.700 | 0.500 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
microRNA 146a | 0.398 | 0.885 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
microRNA 222 | 0.486 | 0.808 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
microRNA 384 | 0.612 | 0.731 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
prostate cancer associated 3 | 0.663 | 0.615 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 2008 | 2017 | ||||||||
|
timeless circadian regulator | 0.533 | 0.808 | 9.8E-35 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
insulin receptor related receptor | 0.508 | 0.808 | 5.4E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
transglutaminase 2 | 0.445 | 0.808 | 6.8E-18 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2011 | 2013 | ||||||||
|
apolipoprotein B | 0.453 | 0.808 | 1.9E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
muscular LMNA interacting protein | 0.682 | 0.577 | 3.2E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
transmembrane and coiled-coil domains 3 | 0.931 | 0.077 | 4.9E-16 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
erb-b2 receptor tyrosine kinase 3 | 0.448 | 0.808 | 1.7E-15 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2006 | 2006 | ||||||||
|
MEFV innate immuity regulator, pyrin | 0.440 | 0.885 | 1.0E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
Rho guanine nucleotide exchange factor 5 | 0.526 | 0.808 | 7.6E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
butyrylcholinesterase | 0.447 | 0.923 | 1.1E-13 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 |